Scopia Capital Management’s Prothena Corp PRTA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
Sell
-600,000
Closed -$7.28M 26
2019
Q1
$7.28M Sell
600,000
-4,018,164
-87% -$50.2M 0.27% 22
2018
Q4
$47.6M Buy
4,618,164
+701,757
+18% +$8.34M 1.61% 19
2018
Q3
$51.2M Buy
3,916,407
+405,523
+12% +$5.86M 0.99% 26
2018
Q2
$51.2M Buy
+3,510,884
New +$69.4M 0.89% 29

Other funds holding PRTA

Scopia Capital Management's PRTA Position: Q2 2019 in Review

Scopia Capital Management sold out of Prothena Corp (PRTA) in Q2 2019, closing a stake of 600,000 shares — an estimated $7.28M sold.

Scopia Capital Management first reported a position in PRTA in Q2 2018 and held it in 4 quarters. The position peaked at $51.2M in Q3 2018. 138 funds tracked by Wall St. Rank hold PRTA as of Q2 2019.

  • Scopia Capital Management reported no remaining Prothena Corp position as of Q2 2019 after selling out during the quarter.
  • Scopia Capital Management sold 600,000 Prothena Corp shares in Q2 2019, an estimated $7.28M.
  • Scopia Capital Management first reported a position in Prothena Corp in Q2 2018 and held it in 4 quarters.
  • Scopia Capital Management's Prothena Corp position peaked at $51.2M in Q3 2018.
  • 138 funds tracked by Wall St. Rank held Prothena Corp as of Q2 2019.

Based on Scopia Capital Management's 13F filing for Q2 2019, filed 14 Aug 2019.